Sign in Subscribe
Cancer

Gastric Cancer Study Reveals Potential Therapeutic Strategy Targeting Na+/K+-ATPase a3-Isoform

Strategic Insights

— 1 min read

A new study published in Cell Death and Disease has shed light on the role of Na+/K+-ATPase a3-isoform in the survival of circulating cancer cells in gastric cancer. The research, conducted by a team of scientists at the University of Toyama, found that targeting this enzyme may be a promising therapeutic strategy against gastric cancer.

Researchers examined the role of Na+/K+-ATPase a3-isoform in circulating cancer cells (CCCs) and found that it plays an essential role in their survival. They also discovered that digoxin, a cardiac glycoside, significantly inhibited the enzyme activity and translocation of Na+/K+-ATPase a3-isoform, leading to an increase in anoikis (programmed cell death) in detached (metastatic) gastric cancer cells.

Key Takeaways:

  • Na+/K+-ATPase a3-isoform plays a crucial role in the survival of circulating cancer cells in gastric cancer.
  • Digoxin inhibits the enzyme activity and translocation of Na+/K+-ATPase a3-isoform, leading to an increase in anoikis in detached (metastatic) gastric cancer cells.
  • The study suggests that targeting Na+/K+-ATPase a3-isoform may be a promising therapeutic strategy against gastric cancer.
  • The research provides new insights into the role of Na+/K+-ATPase a3-isoform in gastric cancer and its potential as a therapeutic target.
  • The study highlights the importance of further research on the potential of digoxin as a treatment for gastric cancer.

Statistics:

  • The study found that digoxin significantly inhibited the enzyme activity and translocation of Na+/K+-ATPase a3-isoform in 20-fold and 50-fold concentrations, respectively.
  • The number of circulating cancer cells in the liver metastasis model was significantly reduced in mice treated with digoxin (2 mg/kg/day) compared to the control group.
  • The study found that the expression of cleaved caspase 3, a marker of anoikis, was significantly increased in digoxin-treated cells compared to the control group.
  • The viability of detached (floating) cells was significantly reduced in digoxin-treated cells compared to the control group.

Sources:

  • Cell Death and Disease. "Digoxin promotes anoikis of circulating cancer cells by targeting Na+/K+-ATPase a3-isoform." Vol. 16, Issue 1 (2025): 1-12.
  • Nature Publishing Group. "Cell Death and Disease." [online] Available at: http://www.nature.com/cddis/index.html
  • University of Toyama. "Department of Surgery and Science, Faculty of Medicine, Academic Assembly."

Read more